loperamide sold brand name imodium among medication opioid receptor agonist class used decrease frequency often used purpose irritable bowel syndrome inflammatory bowel disease short bowel recommended blood stool mucus stool medication taken common side effects include abdominal pain constipation sleepiness vomiting dry may increase risk toxic loperamides safety pregnancy unclear evidence harm appears safe opioid significant absorption gut cross barrier used normal works slowing contractions loperamide first made used medically world health organizations list essential loperamide available generic commonly prescribed medication united states loperamide effective treatment number types includes control acute nonspecific diarrhea mild travelers diarrhea irritable bowel syndrome chronic diarrhea due bowel resection chronic diarrhea secondary inflammatory bowel disease also useful reducing ileostomy output offlabel uses loperamide also include chemotherapyinduced diarrhea especially related irinotecan use loperamide used primary treatment cases bloody diarrhea acute exacerbation ulcerative colitis bacterial loperamide often compared diphenoxylate studies suggest loperamide effective lower neural side adverse drug reactions commonly associated loperamide constipation occurs users dizziness nausea abdominal cramps rare serious side effects include toxic megacolon paralytic ileus angioedema anaphylaxisallergic reactions toxic epidermal necrolysis syndrome erythema multiforme urinary retention heat frequent symptoms loperamide overdose drowsiness vomiting abdominal pain high doses may result heart problems abnormal heart treatment avoided presence high fever stool bloody treatment recommended people could negative effects rebound constipation suspicion exists diarrhea associated organisms penetrate intestinal walls e coli salmonella loperamide contraindicated primary loperamide treatment used symptomatic c difficile infections increases risk toxin retention precipitation toxic megacolon loperamide administered caution people liver failure due reduced firstpass additionally caution used treating people advanced hivaids cases viral bacterial toxic megacolon reported abdominal distension noted therapy loperamide use loperamide children two years recommended rare reports fatal paralytic ileus associated abdominal distention made reports occurred setting acute dysentery overdose young children less two years review loperamide children years old found serious adverse events occurred children three years old study reported use loperamide contraindicated children systemically ill malnourished moderately dehydrated bloody formulations children antidiarrheal loperamide banned national health service united kingdom recommends loperamide given children age twelve prescribed doctor formulations children available prescription loperamide recommended united kingdom use pregnancy nursing us loperamide classified us food drug administration fda pregnancy category c studies rat models shown teratogenicity sufficient studies humans one controlled prospective study women exposed loperamide first trimester pregnancy showed increased risk malformations however one study small sample loperamide present breast milk recommended breastfeeding loperamide substrate pglycoprotein therefore concentration loperamide increases given pglycoprotein common pglycoprotein inhibitors include quinidine ritonavir loperamide capable decreasing absorption drugs example saquinavir concentrations decrease half given loperamide antidiarrheal agent decreases intestinal movement combined antimotility drugs risk constipation increased drugs include opioids antihistamines antipsychotics loperamide opioidreceptor agonist acts Î¼opioid receptors myenteric plexus large intestine works like morphine decreasing activity myenteric plexus decreases tone longitudinal circular smooth muscles intestinal increases time material stays intestine allowing water absorbed fecal matter also decreases colonic mass movements suppresses gastrocolic loperamides circulation bloodstream limited two ways efflux pglycoprotein intestinal wall reduces passage loperamide fraction drug crossing reduced firstpass metabolism loperamide metabolizes mptplike compound unlikely exert efflux pglycoprotein also prevents circulating loperamide effectively crossing generally antagonize muscarinic receptors peripheral nervous system currently score one anticholinergic cognitive burden concurrent administration pglycoprotein inhibitors quinidine potentially allows loperamide cross barrier produce central morphinelike effects high doses loperamide able saturate pglycoprotein thus overcoming efflux produce euphoric loperamide taken quinidine found produce respiratory depression indicative central opioid high doses loperamide shown cause mild physical dependence preclinical studies specifically mice rats rhesus monkeys symptoms mild opiate withdrawal observed following abrupt discontinuation longterm treatment animals loperamide synthesized starting lactone ethyl lab large scale similar synthesis followed except lactone piperidinone produced cheaper materials rather loperamide typically manufactured hydrochloride salt main polymorph melting point second polymorph exists melting point tetrahydrate form identified melts loperamide hydrochloride first synthesized paul janssen janssen pharmaceuticals beerse belgium following previous discoveries diphenoxylate hydrochloride fentanyl citrate first clinical reports loperamide published journal medicinal inventor one authors trial name loperamide oxide different research code trial placebo conducted december february results published journal janssen started promote loperamide brand name imodium december imodium got us fda imodium became bestselling prescription antidiarrheal united march mcneil pharmaceutical began selling loperamide overthecounter drug brand name imodium loperamide also existed form drops imodium drops syrup initially intended childrens usage johnson johnson voluntarily withdrew market cases paralytic ileus resulting six deaths registered pakistan reported world health organization following years products containing loperamide restricted childrens use number countries ranging two five years late us patent expired january mcneil started develop imodium advanced containing loperamide simethicone treating diarrhea gas march company patented drug approved june fda imodium multisymptom relief form chewable caplet formulation approved november november loperamide launched orally disintegrating tablet based zydis loperamide form tablets added model list essential discovered researchers goethe university loperamide effective killing glioblastoma loperamide formerly controlled substance united states first schedule ii controlled substance however lowered schedule v loperamide finally removed control courtesy thenadministrator francis mullen substance remained unregulated controlled substances act ever since loperamide sold generic imodium one biggestselling branded overthecounter medications sold great britain sales loperamide originally marketed imodium many generic brands loperamide typically deemed relatively low risk reports loperamide abuse however case reports extremely highdose loperamide use primary intent users manage symptoms opioid withdrawal diarrhea although small portion derive psychoactive effects higher higher doses central nervous system penetration occurs long term use may lead tolerance dependence withdrawal abrupt dubbing poor mans methadone clinicians warned increased restrictions availability prescription opioids passed response opioid epidemic prompting recreational users turn loperamide overthecounter treatment withdrawal fda responded warnings calling drug manufacturers voluntarily limit package size loperamide publicsafety however quantity restriction number packages purchased pharmacies feel capable restricting sale unclear intervention impact without regulation place loperamide behind since several reports sometimesfatal cardiotoxicity due highdose loperamide abuse httpsenwikipediaorgwikiloperamide